These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33495964)

  • 1. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.
    Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW
    Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Treatment Strategies and Outcomes of Patients With Synchronous Peritoneal Metastases of Gastric Origin: A Nationwide Population-Based Study.
    Guchelaar NAD; Noordman BJ; Welten MW; van Santen MT; de Neijs MJ; Koolen SLW; Verhoeven RHA; Oomen-de Hoop E; van der Sluis PC; Lagarde SM; van Laarhoven HWM; de Hingh IHJT; Creemers GJ; Mostert B; Wijnhoven BPL; Mathijssen RHJ
    J Natl Compr Canc Netw; 2024 Jul; 22(6):405-412. PubMed ID: 39074509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in patients with loco-regionally advanced gastric cancer.
    Hultman B; Gunnarsson U; Nygren P; Sundbom M; Glimelius B; Mahteme H
    World J Surg Oncol; 2017 Sep; 15(1):172. PubMed ID: 28915886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort.
    Rijken A; Bakkers C; van Erning FN; van der Geest LG; de Vos-Geelen J; Besselink MG; Lemmens VE; de Hingh IHJT;
    Pancreas; 2021 Jul; 50(6):827-833. PubMed ID: 34347730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
    Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
    BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
    Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
    Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.
    Yang XJ; Huang CQ; Suo T; Mei LJ; Yang GL; Cheng FL; Zhou YF; Xiong B; Yonemura Y; Li Y
    Ann Surg Oncol; 2011 Jun; 18(6):1575-81. PubMed ID: 21431408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial.
    Rudloff U; Langan RC; Mullinax JE; Beane JD; Steinberg SM; Beresnev T; Webb CC; Walker M; Toomey MA; Schrump D; Pandalai P; Stojadinovic A; Avital I
    J Surg Oncol; 2014 Sep; 110(3):275-84. PubMed ID: 25042700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum.
    Hagiwara A; Sawai K; Sakakura C; Shirasu M; Ohgaki M; Yamasaki J; Togawa T; Takahashi T
    Hepatogastroenterology; 1998; 45(23):1922-9. PubMed ID: 9840177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal metastasis in gastric cancer: results from the German database.
    Rau B; Brandl A; Piso P; Pelz J; Busch P; Demtröder C; Schüle S; Schlitt HJ; Roitman M; Tepel J; Sulkowski U; Uzunoglu F; Hünerbein M; Hörbelt R; Ströhlein M; Beckert S; Königsrainer I; Königsrainer A;
    Gastric Cancer; 2020 Jan; 23(1):11-22. PubMed ID: 31228044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.
    Fanelli MF; Silva MJ; de Paiva TF; Chinen LT; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Melo CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC
    Int J Clin Oncol; 2009 Aug; 14(4):326-31. PubMed ID: 19705243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications.
    Hagiwara A; Togawa T; Yamasaki J; Ohgaki M; Imanishi T; Shirasu M; Sakakura C; Yamaguchi T; Sawai K; Yamagishi H
    Hepatogastroenterology; 1999; 46(27):1673-7. PubMed ID: 10430319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis.
    Hioki M; Gotohda N; Konishi M; Nakagohri T; Takahashi S; Kinoshita T
    World J Surg; 2010 Mar; 34(3):555-62. PubMed ID: 20082194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.
    Rau B; Brandl A; Thuss-Patience P; Bergner F; Raue W; Arnold A; Horst D; Pratschke J; Biebl M
    Gastric Cancer; 2019 Nov; 22(6):1226-1237. PubMed ID: 31065877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Hingh IH; Creemers GJ
    Clin Colorectal Cancer; 2016 Jun; 15(2):e41-6. PubMed ID: 26762572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases.
    Wang YN; Shen KT; Ling JQ; Gao XD; Hou YY; Wang XF; Qin J; Sun YH; Qin XY
    BMC Surg; 2012 Oct; 12():20. PubMed ID: 23062030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review.
    De Andrade JP; Mezhir JJ
    J Surg Oncol; 2014 Sep; 110(3):291-7. PubMed ID: 24850538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.